Collegium Pharma (COLL) Earnings
|
Expand Research on COLL
| Next EPS Date | 11/5/26 | EPS Growth Rate | -17.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +10.1% | Revenue Growth Rate | +11.3% |
| Average % Move 1-Wk after EPS | +12.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q326 | N/A | $1.86 | N/A | N/A | $232.95M | N/A | N/A | N/A | ||
| 8/6/26 |
Q226 | $1.92 | $1.72 | +$0.20 | $199.87M | $201.41M | N/A |  | | Details | |
| 5/7/26 | Q126 | $1.76 | $1.63 | +$0.13 | $193.52M | $187.37M | = | | | Details | |
| 2/26/26 |
Q425 | N/A | $2.14 | N/A | N/A | $207.07M | = | N/A | N/A | ||
| 11/6/25 | Q325 | $2.25 | $1.88 | +$0.37 | $209.36M | $190.12M | = | | | Details | |
| 8/7/25 | Q225 | $1.68 | $1.66 | +$0.02 | $188M | $182.69M | = | | | Details | |
| 5/8/25 |
Q125 | N/A | $1.50 | N/A | N/A | $174.04M | = | N/A | N/A | ||
| 2/27/25 | Q424 | $1.75 | $1.66 | +$0.09 | $181.9M | $179.48M | = | | | Details |
